Peter Attia· MD
The long-term problems (small uptick in T2D) are very slight and easily prevented.
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
The long-term problems (small uptick in T2D) are very slight and easily prevented.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
there is an actual physiologic problem where statins are causing some increase in the risk of type 2 diabetes
A significant percentage of people taking statins go on to develop diabetes, and diabetes is not something you want to acquire as a drug treatment. It, of course, increases heart disease risk.